Concepedia

Publication | Closed Access

Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

97

Citations

0

References

2002

Year

Abstract

rFVIIa is a promising adjunctive hemostatic treatment for trauma patients suffering from massive bleeding. Controlled trials are warranted to evaluate the safety and efficacy of this drug.